Clover Corporation (CLV.AX) Stock Price
Clover Corporation Price
Over the last 19 years Clover Corporation grew revenue by 9.7% annually, reaching 97.41 M AUD. Earnings per share have grown at 15.8% per year over the last 19 years. For Clover Corporation, the net margin of 10.7% is broadly stable versus 10.1% a few years ago. At today's price the dividend yield works out to roughly 1.41%. The payout ratio is around 78% of earnings. The consensus 12-month price target for Clover Corporation is 0.89 AUD, about 12.6% below where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
Clover Corporation stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Clover Corporation business model & stock analysis
Frequently asked questions about Clover Corporation
The business model of Clover Corporation Ltd revolves around the production and distribution of innovative ingredients and formulations for various industries. Clover Corporation specializes in the development of nutritional oils and microencapsulation technology. Their products are specifically designed to enhance the nutritional value and bioavailability of essential fatty acids, particularly DHA and EPA, which are crucial for infant formula, medical foods, and functional foods. By leveraging their expertise in lipid technology, they cater to global customers in the pharmaceutical, nutritional, and food manufacturing sectors. With a focus on quality and sustainability, Clover Corporation aims to provide reliable solutions that promote health and well-being.
Clover Corporation Ltd primarily operates in the industries of food ingredients and pharmaceuticals.
Some of the main competitors of Clover Corporation Ltd in the market include ABC Co., XYZ Inc., and LMN Corp. These companies offer similar products and services as Clover Corporation Ltd, striving to capture a share of the market. However, Clover Corporation Ltd sets itself apart through its innovative solutions, exceptional quality, and strong customer relationships. With its strategic positioning and constant focus on delivering value to its clients, Clover Corporation Ltd remains a formidable presence in the market amidst competition.
Clover Corporation Ltd is an Australian company specializing in the research, development, manufacture, and distribution of innovative ingredients and products for the global food, beverage, and pharmaceutical industries. Established in 1986, Clover Corporation has successfully positioned itself as a leader in microencapsulation technology, providing unique solutions for encapsulating and protecting sensitive ingredients. The company's commitment to quality and scientific excellence has helped it expand its presence globally, with operations across the Asia-Pacific, Europe, and the Americas. As a trusted provider of innovative ingredients, Clover Corporation continues to drive advancements in nutrition and wellness, contributing to the success of its clients and stakeholders.
Clover Corporation Ltd has achieved several significant milestones throughout its history. One notable achievement is its establishment as a leading provider of innovative ingredients and solutions for the global functional food and nutraceutical industries. The company stands out for its continuous dedication to research and development, resulting in the successful commercialization of encapsulated ingredients that enhance the nutritional value and stability of various products. Clover Corporation Ltd has also cemented its position as a trusted partner, serving major multinational companies in the infant formula and pharmaceutical sectors. With a steadfast commitment to excellence and cutting-edge solutions, Clover Corporation Ltd has consistently proven itself as a pioneer in its field.
Clover Corporation Ltd is primarily present in Australia and New Zealand. The company operates in these countries and regions, focusing on the production and distribution of high-quality nutritional ingredients and essential fatty acids. With a strong presence in its home market of Australia, Clover Corporation Ltd has expanded its reach to New Zealand, catering to the growing demand for specialty ingredients in the region.
Clover Corporation Ltd represents the values of innovation, quality, and sustainability. With a strong corporate philosophy focused on delivering cutting-edge solutions, Clover Corp strives to develop and produce high-value ingredient products for the global food, health, and nutrition industries. The company is committed to preserving the environment through sustainable practices and maintaining high ethical standards in all its operations. By continuously investing in research and development, Clover Corp aims to provide customers with innovative and reliable solutions, while also creating long-term value for its stakeholders.
Analysts currently set an average price target of 0.89 AUD for the Clover Corporation stock (median: 0.89 AUD), implying -12.6 % versus the latest price. The consensus is based on 5 analyst ratings.
5 analysts currently rate the Clover Corporation stock: 4 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Clover Corporation share trades at 0.63 EUR (1.01 AUD).
The Clover Corporation share (CLV.AX) is listed on 1 stock exchanges, including: ASX (CLV.AX).
Clover Corporation Ltd is a globally operating company specializing in the manufacturing and distribution of ingredients and products for the food, beverage, and beauty industry. The company has been active since 1986 and its headquarters are located in Sydney, Australia. The company is divided into the following business segments: 1. Food and beverage additives Clover Corporation Ltd offers a wide range of ingredients that food and beverage manufacturers can use in their products. These ingredients include omega-3 fatty acids derived from marine sources such as fish oil, as well as plant oils like flaxseed, hemp, canola, and sunflower oil. These ingredients not only provide functional benefits, such as extending shelf life or improving texture, but also offer health benefits, such as improving cognitive function and cardiovascular health. 2. Animal health Clover Corporation Ltd also produces supplements for livestock, allowing them to obtain all the necessary nutrients for healthy growth. The supplements include omega-3 fatty acids, vitamins, and minerals, and are available in the form of pellets, oils, and powders. 3. Beauty and skincare products Clover Corporation Ltd is also involved in the production of ingredients for the beauty and skincare industry. These ingredients include omega-3 fatty acids that improve skin appearance, as well as natural oils that provide hydration and smoothness to the skin. The products are available in the form of serums, creams, and lotions. Clover Corporation Ltd focuses on research and development to develop new products that meet the needs of its customers. The company has a strong presence in Asia, Europe, North America, and Australia, and distributes its products through a network of wholesalers, distributors, and direct customers. The company has also formed partnerships with other companies in the food and beauty industry to include its products in their product range. The vision of Clover Corporation Ltd is to be a global leading provider of ingredients for the food, beverage, and beauty industry, and the company is on track to achieve this goal. With a strong focus on research, development, and innovation, Clover Corporation Ltd will continue to deliver products that meet the needs of its customers and contribute to improving global health.
The revenue of Clover Corporation is 97.41 M AUD. This figure is based on current financial data and reflects the company's business performance.
The profit of Clover Corporation is 10.46 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Clover Corporation is currently 16.21. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Clover Corporation stock.
The price-to-sales ratio (P/S) of Clover Corporation is currently 1.74. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Clover Corporation stock.
The Eulerpool Quality Score for Clover Corporation is 8/10.
The ISIN of Clover Corporation is AU000000CLV2. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Clover Corporation is 936367. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Clover Corporation is CLV.AX. The ticker symbol is used to trade Clover Corporation shares on the stock exchange.
Clover Corporation stock
Clover Corporation Peer Group
Clover Corporation Ticker
Clover Corporation FIGI
All fundamentals and in-depth analysis of Clover Corporation
Our stock analysis for Clover Corporation stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clover Corporation. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.